Endoscopic thyroidectomy, originally introduced during the mid-1990s, has recently gained popularity among various health care facilities for its obvious cosmetic advantages. But with its increased popularity comes increased risks of adverse effects \[[@B1]\]. Most events are respiratory complications resulting from the body\'s absorption of carbon dioxide (CO~2~) used during the surgery: the reported side effects include hypercapnia, subcutaneous emphysema, mediastinal emphysema, and pulmonary embolism. Pneumothorax, however, has not been reported yet. We experienced pneumothorax during an endoscopic thyroidectomy and hereby present the case with a review of the literature.

Case Report
===========

A 22-year-old woman, weighing 51 kg, visited this hospital, complaining of a thyroid nodule and septal deviation. It was decided that an endoscopic thyroidectomy and septoplasty was to be performed on her. Our review of medical history and a preoperative examination showed no particular conditions to consider. Prior to the surgery, patient\'s condition was monitored via ECG and noninvasive blood pressure monitoring; Oxygen saturation and end-tidal CO~2~ pressure (PetCO~2~) were measured. After the IV infusion of thiopental sodium (250 mg) and vecuronium (6 mg), endotracheal intubation was performed with no particular problems. General anesthesia was induced and maintained with O~2~ 2 L/min, N~2~O 2 L/min, and sevoflurane. Mechanical ventilation was provided with a tidal volume of 500 ml, a respiratory rate of 10/min, and a peak inspiratory pressure (PIP) of 18 cmH~2~O. Oxygen saturation after the induction of anesthesia was 99%; PetCO~2~ was 34-36 mmHg.

A small incision was made in the patient\'s right armpit area, through which two trocars, 10 mm and 12 mm in diameter, were each inserted; another 12 mm trocar was infiltrated through an incision made in the area above right nipple; all trocars were inserted beneath the pectoral muscles. CO~2~ was continuously administered under the platysma muscle at 8 mmHg to create an air pocket and to allow the surgery to proceed.

About 30 minutes after the injection of CO~2~, PetCO~2~ and PIP started to show a gradual increase; after 40 minutes, the PetCO~2~ and PIP reached 41 mmHg and 22 cmH~2~O, respectively. Thus, the respiration rate was increased to 14/min while maintaining the tidal volume. The PetCO~2~ and PIP continued to increase in small increments until approximately 50 minutes after the CO~2~ injection, at which point the PetCO~2~ soared abruptly to 49 mmHg and the PIP to 35 cmH~2~O, while the oxygen saturation dropped to 94%. When this occurred, the patient\'s vitals were a blood pressure of 118/70 mmHg and a heart rate of 100 beats/min. Mechanical ventilation was immediately shifted to manual ventilation; 100% oxygen was administered; both of lungs were examined with a stethoscope because we suspected pneumothorax after excluding the possibilities of respiratory obstruction resulting from one lung ventilation or secretion, or the possibilities of a bent tube or interruption in the respiratory cycle. Respiratory sounds from left lung were normal, but the sounds from right lung were diminished. During the stethoscopy, crepitant rales were heard as well, and thus the patient\'s condition was checked. Subcutaneous emphysema was found in the neck, shoulders, arms, and thoracic wall. Thus, an arterial blood gas analysis was done, which revealed a pH of 7.24, a PaCO~2~ of 54.6 mmHg, a PaO~2~ of 162.5 mmHg, a SaO~2~ at 99%, and a base excess of -3.6 mEq/L - all of which indicated respiratory acidosis. Chest X-rays showed pneumothorax in right lung ([Fig. 1](#F1){ref-type="fig"}). A chest tube was inserted into right lung; multiple manual ventilations were carried out to achieve a full expansion of the lung. The anesthesia was maintained with O~2~-air-sevoflurane. At this point, PetCO~2~ decreased to 37 mmHg, and PIP to 19 cmH~2~O. After making sure the patient\'s respiratory condition was stabilized, the operation was resumed. About 10 minutes into the surgery, PetCO~2~ increased gradually to 46 mmHg, whereas PIP remained the same. At this point, another arterial blood gas analysis was done, which showed a pH of 7.27, a PaCO~2~ of 51.6 mmHg, a PaO~2~ of 317.8 mmHg, a SaO~2~ at 99%, and a base excess of -3.2 mEq/L. Blood pressure was 120/80 mmHg; heart rate was 98 beats/min. We assumed that the hypercapnia would probably continue due to the increased absorption of CO~2~ because of the subcutaneous emphysema. Thus, we consulted with the surgeon and decided to continue only with the endoscopic thyroidectomy and to delay the septoplasty.

The surgery was finished two hours and 20 minutes after the insertion of the chest tube. Extubation took place in the operating room after ensuring a full recovery of the patient\'s respiration and consciousness. The patient did not exhibit any difficulty breathing.

Upon arrival at the recovery area, oxygen (5 L) was delivered via a facemask. An arterial blood gas analysis, done 15 minutes after the administration of oxygen, revealed a pH of 7.34, a PaCO~2~ of 33.5 mmHg, a PaO~2~ of 190.6 mmHg, a SaO~2~ at 99%, and a base excess of -6.0 mEq/L. The chest X-rays showed only mild subcutaneous emphysema ([Fig. 2](#F2){ref-type="fig"}). A CT scan two days postoperatively revealed no adverse events such as lung bulla. The patient was discharged on the fifth day after the operation without exhibiting any particular complications.

Discussion
==========

An ideal gas for gas injection during a laparoscopy should have minimal absorption into the abdominal cavity as well as minimal physiological effects; be quickly discharged from the body; and have no inflammability yet high solubility in blood \[[@B2]\]. CO~2~ matches those parameters closely and is frequently used in laparoscopic or endoscopic procedures. In the case of pneumoperitoneum, CO~2~ can be eliminated quickly and helps minimize the patient\'s postoperative discomfort. Its many advantages notwithstanding, CO~2~, when absorbed into the blood, can cause hypercapnia, subcutaneous emphysema, pneumothorax, and embolism \[[@B3],[@B4]\].

During a laparoscopic abdominal surgery, the absorption of CO~2~ in the body continues to increase for the first 20 minutes until it levels out. On the contrary, during a laparoscopic procedure done in sites other than the abdominal/pelvic cavity, the absorption of CO~2~ continues to increase over time, reportedly resulting in hypercapnia and subcutaneous emphysema that are worse than that of those occurring during laparoscopic abdominal surgeries. Mechanisms behind such difference are two-fold: (a) with an abdominal gas injection pressure of 10-12 mmHg or above, the blood flow into the capillaries decreases, resulting in a decrease in CO~2~ absorption in the abdominal/pelvic cavity; and (b) during gas injection into a cavity other than the abdominal/pelvic cavity, the continued tissue dissection increases the area that comes in contact with the gas \[[@B5],[@B6]\]. In order to decrease hypercarbia, the respiratory minute ventilation must be increased and the gas injection pressure decreased. Generally speaking, the PetCO~2~ can be normalized during a laparoscopy by increasing the respiratory minute ventilation by 35-60% \[[@B3],[@B5]\].

Hemodynamic and respiratory adverse events, resulting from hypercapnea during a laparoscopy, are influenced by the pressure at which CO~2~ is injected. During endoscopic neck surgery, a CO~2~ injection pressure of 10 mmHg or lower is considered safe, whereas a pressure of 15 mmHg or above reportedly causes severe hypercapnia and acidosis \[[@B1]\]. Ochiai et al. \[[@B7]\] reported that the prevention of hypercarbia was achieved by using only 6 mmHg of gas injection pressure during an endoscopic thyroidectomy, which was enough to secure an operative space.

During a laparoscopic/endoscopic surgery, it is difficult to predict the partial pressure of carbon dioxide in arterial blood (PaCO~2~) with the PetCO~2~ because the alveolar-arterial oxygen gradient is not on the line when PetCO~2~ is higher \[[@B8]\]. Therefore, if the PetCO~2~ during a laparoscopic/endoscopic procedure is found to be higher, it is important to do arterial blood gas analyses frequently and use the information to measure the PetCO~2~ \[[@B9]\].

While trying to figure out the cause of the hypercapnia occurring during a laparoscopic/endoscopic surgery, clinicians must determine whether the condition is due to a meager increase in the amount of CO~2~ absorbed or is the result of other factors - such as hypoventilation resulting from respiratory obstruction or leakage in the respiratory cycle; abdominal inflation; posture of the patient; a ventilation-perfusion mismatch resulting from decreased cardiac output; and a host of other reasons including embolism, pneumothorax, subcutaneous emphysema, endotracheal intubation, and malignant hyperthermia \[[@B10]\].

Subcutaneous emphysema can be caused by the gathering of gas under the skin, which occurs during a laparoscopic/endoscopic procedure, and can be detected by feeling the vibrations from the crepitant rales. The emphysema is accompanied by increased airway pressure and elevated levels of PetCO~2~ and these conditions could result in marked hypercapnia as well as respiratory acidosis. According to Sumpf et al. \[[@B5]\], an incident of subcutaneous emphysema during a laparoscopic extraperitoneal pelvic procedure resulted in the CO~2~ absorption three times the CO~2~ absorption observed during a similar procedure where subcutaneous emphysema did not occur. The researchers reported that they were not able to normalize the PetCO~2~, despite the marked increase in the respiratory minute ventilation. Their results imply that it is important for clinicians to suspect the occurrence of subcutaneous emphysema during a laparoscopic/endoscopic surgery if they observe continued hypercapnea during the procedure despite the typical increase in minute ventilation.

In the event of subcutaneous emphysema, the use of N~2~O must be discontinued, and the gas injection pressure be reduced. In the case of subcutaneous emphysema in the head and/or the neck, the pharynx should be observed directly by using a laryngoscope before removing the tube from inside the trachea. Direct observation is necessary since respiratory obstruction may result from emphysema in the pharynx \[[@B11]\].

Alveolar rupture and iatrogenic damages to the pleura or the diaphragm are among the causes of pneumothorax that is associated with anatomical damages occurring during laparoscopy. If a patient was suffering from lung bullae, that condition could lead to increased risks of alveolar rupture due to increases in respiratory minute ventilation that are intended to treat hypercapnia. Pneumothorax, which occurs without causing anatomical damages in patients, can result from either congenital defects found between the pleural and abdominal cavities; from the injected gas migrating into the thoracic area along with the retroperitoneal space; from gas leakage resulting from a high injection pressure; or from the migration of gas through the weakest site in the aortic or esophageal hiatus when the surgery takes a long time \[[@B12]\]. Subcutaneous emphysema spreading widely across the abdominal area could further spread to the thoracic wall and then to the neck, following the continuous planes of the fascia; subcutaneous emphysema in the neck and face may cause gas tracking in the thoracic area and mediastinum, possibly resulting in pneumothorax and mediastinal emphysema \[[@B3]\]. In our case report, postoperative CT scans showed no abnormalities in the patient\'s lungs; no noteworthy events occurred either during the surgery, which might lead to iatrogenic damages; however, severe subcutaneous emphysema was found in the neck, shoulders, and thoracic wall. Based on these findings, we suspect the patient\'s pneumothorax was caused by gas tracking resulting from subcutaneous emphysema. Thus, we recommend mandatory postoperative chest X-rays for patients with subcutaneous emphysema in the neck, though perhaps asymptomatic, to exclude the possibilities of pneumothorax and mediastinal emphysema \[[@B10]\].

Symptoms of pneumothorax vary widely from no symptoms to cardiac arrest, depending on the size of the pneumothorax and its development speed, which affects the patient\'s cardiovascular system, as well as on the patient\'s cardiopulmonary functioning. The symptoms may also include increased PIP, decreased pulmonary compliance, increased PetCO~2~, decreased oxygen saturation, and hypotension \[[@B12]\].

To treat pneumothorax during a laparoscopy, clinicians need to stop the infusion of CO~2~ or reduce the injection pressure, discontinue the use of N~2~O, increase hyperventilation and the fraction of inspired oxygen, and maintain hemodynamic stability when necessary. Pleural puncture may not be needed unless to treat unstable respiration or the hemodynamic condition of the patient since CO~2~ is easily absorbed in the body \[[@B13]\]. Joris et al. \[[@B14]\] reported they treated pneumothorax during a laparoscopic Nissen fundoplication by applying PetCO~2~ without performing thoracentesis. They argued that the treatment worked because PetCO~2~ helped reduce the difference in pressure between the abdominal and thoracic cavities, expanded the contracted lungs, and prevented mechanically the defects in the visceral pleura.

Hypercapnia, subcutaneous emphysema, pneumothorax, and mediastinal emphysema encountered during laparoscopy are reportedly the result of a long surgery lasting more than 200 minutes or high PetCO~2~ levels (50 mmHg or above), and their likelihood reportedly increases with a growing number of trocars used during the surgery and with a patient with advanced age \[[@B15]\]. However, clinicians must remember that complications can occur anytime, as in our case where there were not many risk factors to trigger the complications.

In conclusion, clinicians are advised to suspect subcutaneous emphysema during endoscopic thyroidectomy when hypercapnia is not corrected with an increase in the respiratory minute ventilation, which is a standard approach in dealing with hypercapnia, as well as the resulting possibility of pneumothorax. Clinicians are also advised to consider the possibilities of intraoperative hemodynamic and respiratory complications. When suspecting such complications, clinicians must closely monitor the patient\'s PetCO~2~, oxygen saturation, PIP, and pulmonary compliance. Close consultation with the surgeon is also required to take into account the inspired gas pressure, duration of the surgery, and other related factors.
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